At a glance · for buyers and watchdogs
Terumo Blood and cell Technologies has won — across 1 public-sector buyer, with 1 live contract.
Why: top buyer The Royal Marsden NHS Foundation Trusts at 0% · 0 active risk flags · 0 modifications.
Decision signals
Active red flags0
Company statusNo CH record
Live contracts1 of 1
Top-buyer concentration0%
Category exposure—
Contract modifications0
About this supplier
Supplier-written pitch — services, mission, and a hero image.
—
No supplier-written profile yet
When a supplier verifies ownership of this page they can publish a pitch, link their website, and request meetings. Until then we only show independently sourced data below.
Social value projects
Outcomes attributed by the supplier, each linked to its source contract.
No social-value projects published
Jobs, skills, environmental and inequality outcomes appear here once a claimed supplier attributes them to awarded contracts. We mark each as self-reported or buyer-confirmed.